Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome

Cancer Research

Volumn 57, Issue 12, 1997, Pages 2501-2507

  Von Wasielewski, Reinhard ^a   Rhein, Axel ^b   Werner, Martin ^c   Scheumann, Georg F W ^b   Dralle, Henning ^d   Pötter, Eyck ^a   Brabant, Georg ^a   Georgii, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Abt F Abdom T   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ARTICLE; CANCER RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RELAPSE; THYROID CARCINOMA;

BIOPSY; CADHERINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 0030956853     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hedinger, C., Williams, E. D., and Sobin, L. H. Histological typing of thyroid tumours. Berlin: Springer Verlag, 1988.
2. Palestini, N., Cappello, N., Cottino, F., Durando, R., Vecchiato, D., Rendine, S., and Abeatici, S. Multifactorial study of prognostic factors in differentiated thyroid carcinoma. Ital. J. Surg. Sci., 19: 137-144, 1989.
3. Akslen, L. A., Haldorsen, T., Thoresen, S. O., and Glattre, E. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res., 51: 1234-1241, 1991.
4. Shah, J. P., Loree, T. R., Dharker, D., Strong, E. W., Begg, C., and Vlamis, V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am. J. Surg., 164: 658-661, 1992.
5. Cady, B., and Rossi, R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 104: 947-953, 1988.
6. Shaha, A. R., Loree, T. R., and Shah, J. P. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery, 116: 1036-1040, 1994.
7. Farahati, J., Reiners, C., Stuschke, M., Muller, S. P., Stuben, G., Sauerwein, W., and Sack, H. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer (Phila.), 77: 172-180, 1996.
8. Tsuchiya, A., Suzuki, S., Kanno, M., Kikuchi, Y., Ando, Y., and Abe, R. Prognostic factors associated with differentiated thyroid cancer. Surg. Today, 25: 778-782, 1995.
9. Kobayashi, T., Asakawa, H., Tamaki, Y., Umeshita, K., and Monden, M. Fatal differentiated thyroid cancer. J. Surg. Oncol., 62: 123-127, 1996.
10. Takeichi, M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development (Camb.), 102: 639-655, 1988.
11. Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science (Washington DC), 251: 1451-1455, 1991.
12. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D., and Birchmeier, W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113: 173-185, 1991.
13. Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W., and Van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66: 107-119, 1991.
14. Serini, G., Trusolino, L., Saggiorato, E., Cremona, O., De Rossi, M., Angeli, A., Orlandi, F., and Marchisio, P. C. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J. Natl. Cancer Inst., 88: 442-449, 1996.
15. Nose, A., Tsuji, K., and Takeichi, M. Localization of specificity determining sites in cadherin cell adhesion molecules. Cell, 61: 147-155, 1990.
16. Dorudi, S., Sheffield, J. P., Poulsom, R., Northover, J. M., and Hart, I. R. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am. J. Pathol., 142: 981-986, 1993.
17. Gamallo, C., Palacios, J., Suarez, A., Pizarro, A., Navarro, P., Quintanilla, M., and Cano, A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am. J. Pathol., 142: 987-993, 1993.
18. Mattijssen, V., Peters, H. M., Schalkwijk, L., Manni, J. J., van't Hof Grootenhoer, B., de Mulder, P. H., and Ruiter, D. J. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int. J. Cancer, 55: 580-585, 1993.
19. Scheumann, G. F., Hoang Vu, C., Cetin, Y., Gimm, O., Behrens, J., von Wasielewski, R., Georgii, A., Birchmeier, W., von Zur Muhlen, A., Dralle, H., and Brabant, G. Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas. J. Clin. Endocrinol. Metab., 80: 2168-2172, 1995.
20. Shiozaki, H., Oka, H., Inoue, M., Tamura, S., and Monden, M. E-cadherin mediated adhesion system in cancer cells. Cancer (Phila.), 77: 1605-1613, 1996.
21. Shiozaki, H., Tahara, H., Oka, H., Miyata, M., Kobayashi, K., Tamura, S., Iihara, K., Doki, Y., Hirano, S., Takeichi, M., and Mori, T. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am. J. Pathol., 139: 17-23, 1991.
22. Mayer, B., Johnson, J. P., Leitl, F., Jauch, K. W., Heiss, M. M., Schildberg, F. W., Birchmeier, W., and Funke, I. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res., 53: 1690-1695, 1993.
23. Lipponen, P., Saarelainen, E., Ji, H., Aaltomaa, S., and Syrjanen, K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J. Pathol., 174: 101-109, 1994.
24. Bringuier, P. P., Umbas, R., Schaafsma, H. E., Karthaus, H. F., Debruyne, F. M., and Schalken, J. A. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res., 53: 3241-3245, 1993.
25. Dorudi, S., Hanby, A. M., Poulsom, R., Northover, J., and Hart, I. R. Level of expression of E-eadherin mRNA in colorectal cancer correlates with clinical outcome. Br. J. Cancer, 71: 614-616, 1995.
26. Bongiorno, P. F., al Kasspooles, M., Lee, S. W., Rachwal, W. J., Moore, J. H., Whyte, R. I., Orringer, M. B., and Beer, D. G. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barren's oesophagus. Br. J. Cancer, 71: 166-172, 1995.
27. Shimoyama, Y., and Hirohashi, S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett., 57: 131-135, 1991.
28. Oka, H., Shiozaki, H., Kobayashi, K., Tahara, H., Tamura, S., Miyata, M., Doki, Y., lihara, K., Matsuyoshi, N., Hirano, S., Takeichi, M., and Mori, T. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch. A Pathol. Anat. Histopathol., 421: 149-156, 1992.
29. Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., Takeichi, M., and Mori, T. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res., 53: 1696-1701, 1993.
30. Brabant, G., Hoang Vu, C., Cetin, Y., Dralle, H., Scheumann, G., Molne, J., Hansson, G., Jansson, S., Ericson, L. E., and Nilsson, M. E-cadherin: a differentiation marker in thyroid malignancies. Cancer Res., 53: 4987-4993, 1993.
31. Kinsella, A. R., Green, B., Lepts, G. C., Hill, C. L., Bowie, G., and Taylor, B. A. The role of the cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br. J. Cancer, 67: 904-909, 1993.
32. Kadowaki, T., Shiozaki, H., Inoue, M., Tamura, S., Oka, H., Doki, Y., Iihara, K., Matsui, S., Iwazawa, T., Nagafuchi, A., and Tsukita, S., and Mori, T. E-eadherin and α-catenin expression in human esophageal cancer. Cancer Res., 54: 291-296, 1994.
33. Curruba, G., Miceli, D., d'Amico, D., Farruggio, R., Comito, L., Montesanti, A., Polito, L., and Castagnetta, L. A. Sex steroids up-regulale E-cadherin expression in hormone-responsive LNCaP human prostate cancer cells. Biochem. Biophys. Res. Commun., 212: 624-631, 1995.
34. Bracke, M. E., Charlier, C., Bruyneel, E. A., Labit, C. Mareel, M. M., and Castronovo, V. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res., 54: 4607-1609, 1994.
35. Fujimoto, J., Ichigo, S., Hori, M., Morishita, S., and Tamaya, T. Progestins and danazol effects on cell-to-cell adhesion, and E-cadherin and α- and β-catenin mRNA expressions. J. Steroid Biochem. Mol. Biol., 57: 275-282, 1996.
36. Fialka, I., Schwarz, H., Reichmann, E., Oft, M., Busslinger, M., and Beug, H. The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J. Cell Biol., 132: 1115-1132, 1996.
37. Akslen, L. A., and Varhaug, J. E. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival. Cancer (Phila.), 76: 1643-1654, 1995.
38. Behrens, J., Mareel, M. M., Van Roy, F. M., and Birchmeier, W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol., 108: 2435-2447, 1989.
39. Tsuda, H., Zhang, W., Shimasato, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T., and Hirohshashi, S. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87: 6791-6794, 1990.
40. Natt, E., Magenis, R. E., Zimmer, J., Mansouri, A., and Scherer, G. Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsinogen B (CTRB) with the help of two overlapping deletions on the long arm of chromosome 16. Cytogenet. Cell Genet., 50: 145-148, 1989.
41. Soares, P., Berx, G., van Roy, F., and Sobrinho-Simoes, M. E-cadherin gene alterations are rare events in thyroid tumors. Int. J. Cancer. 70: 32-38, 1997.
42. Tannapfel, A., Yasui, W., Yolozaki, H., Wittekind, C., and Tahura, H. Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines. Virchows Arch., 425: 139-144, 1994.
43. Schipper, J. H., Frixen, U. H., Behrens, J., Unger A., Jahnke, K., and Birchmeier, W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res., 51: 6328-6337, 1991.
44. Schipper. J. H., Linger, A., and Jahnke, K. E-cadherin as a functional marker of the differentiation and invasiveness of squamous cell carcinoma of the head and neck. Clin. Otolaryngo., 19: 381-384, 1994.
45. Rasbridge, S. A., Gillett, C. E., Sampson, S. A., Walsh, F. S., and Millis, R. R. Epithelial (E-) and plucental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J. Pathol., 169: 245-250, 1993.
46. Siitonen, S. M., Kononen, J. T., Helin, H. J., Rantala, I. S., Holli, K. A., and Isola, J. J. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol., 105: 394-402, 1996.